Thomas J. Herzfeld Advisors, Inc. Novartis Ag Transaction History

Thomas J. Herzfeld Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $113,676 - $126,156	1,200 New	1,200 $116 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $3,324 - $4,070	-44 Reduced 3.54%	1,200 $108,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $1,022 - $1,129	12 Added 0.97%	1,244 $114,000
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $11,006 - $12,389	-136 Reduced 9.94%	1,232 $101,000
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $1,539 - $1,696	18 Added 1.33%	1,368 $119,000
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $55,117 - $67,836	731 Added 118.09%	1,350 $123,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $2,485 - $2,842	33 Added 5.63%	619 $52,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $6,334 - $7,053	86 Added 17.2%	586 $50,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $37,070 - $38,635	500	500 $43,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.